Institute of Intensive Care Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland.
Plastic and Hand Surgery, Cantonal Hospital Aarau, Tellstrasse 25, CH-5001 Aarau, Switzerland.
Cytokine. 2023 Sep;169:156266. doi: 10.1016/j.cyto.2023.156266. Epub 2023 Jun 22.
Angiopoietin-2 (Angpt-2) is involved in the pathogenesis of the capillary leak syndrome in sepsis and has been shown to be associated with worse outcomes in diverse critical illnesses. It is however unclear whether Angpt-2 plays a similar role in severely burned patients during the early phase characterized by massive capillary leakage. Our aim was to analyze the Angiopoietin-2/Angiopoietin-1 ratio (Angpt-2/Angpt-1 ratio) over the first two days in critically ill burn patients and examine its association with survival and further clinical parameters.
Adult burn patients with a total burn surface area (TBSA) ≥ 20% treated in the burn intensive care unit (ICU) of the University Hospital of Zurich, Switzerland, were included. Serum samples were collected prospectively and serum Angpt-1 and Angpt-2 were measured by enzyme-linked immunosorbent assay (ELISA) over the first two days after burn insult and stratified according to survival status, TBSA and the abbreviated burn severity index (ABSI). Due to hemodilution in the initial resuscitation phase, the Angpt-2/Angpt-1 ratio was normalized to albumin.
Fifty-six patients were included with a median age of 51.5 years. Overall mortality was 14.3% (8/56 patients). The total amount of infused crystalloids was 12́902 ml (IQR 9́362-16́770 ml) at 24 h and 18́461 ml (IQR 13́024-23́766 ml) at 48 h. The amount of substituted albumin was 20 g (IQR 10-50 g) at 24 h and 50 g (IQR 20-60 g) at 48 h. The albumin-corrected Angpt-2/Angpt-1 ratios increased over the first 48 h after the burn insult (d0: 0.5 pgl/mlg [IQR 0.24 - 0.80 pgl/mlg]; d1: 0.83 pgl/mlg [IQR 0.29 - 1.98 pgl/mlg]; d2: 1.76 pgl/mlg [IQR 0.70 - 3.23 pgl/mlg]; p < 0.001) and were significantly higher in eventual ICU non-survivors (p = 0.005), in patients with a higher TBSA (p = 0.001) and in patients with a higher ABSI (p = 0.001).
In analogy to the pathological host response in sepsis, the Angpt-2/Angpt-1 ratio steadily increases in the first two days in critically ill burn patients, suggesting a putative involvement in the pathogenesis of capillary leakage in burns. A higher Angpt-2/Angpt-1 ratio is associated with mortality, total burn surface area and burn scores.
血管生成素-2(Angpt-2)参与脓毒症毛细血管渗漏综合征的发病机制,并且已被证明与不同危重疾病的预后较差有关。然而,在以大量毛细血管渗漏为特征的早期阶段,Angpt-2 是否在严重烧伤患者中发挥类似作用尚不清楚。我们的目的是分析危重病烧伤患者前 2 天的血管生成素-2/血管生成素-1 比值(Angpt-2/Angpt-1 比值),并研究其与生存和进一步的临床参数的关系。
纳入瑞士苏黎世大学医院烧伤重症监护病房(ICU)接受总面积烧伤(TBSA)≥20%的成年烧伤患者。前瞻性采集血清样本,通过酶联免疫吸附试验(ELISA)在前烧伤后 2 天内测量血清 Angpt-1 和 Angpt-2,并根据生存状况、TBSA 和简化烧伤严重程度指数(ABSI)进行分层。由于初始复苏阶段的血液稀释,将 Angpt-2/Angpt-1 比值归一化为白蛋白。
共纳入 56 例患者,中位年龄为 51.5 岁。总体死亡率为 14.3%(8/56 例患者)。24 小时内输注晶体液总量为 12902ml(IQR 9362-16770ml),48 小时内为 18461ml(IQR 13024-23766ml)。24 小时内替代白蛋白量为 20g(IQR 10-50g),48 小时内为 50g(IQR 20-60g)。烧伤后前 48 小时内白蛋白校正的 Angpt-2/Angpt-1 比值升高(d0:0.5pgl/mlg[IQR 0.24-0.80pgl/mlg];d1:0.83pgl/mlg[IQR 0.29-1.98pgl/mlg];d2:1.76pgl/mlg[IQR 0.70-3.23pgl/mlg];p<0.001),最终 ICU 幸存者(p=0.005)、TBSA 较高者(p=0.001)和 ABSI 较高者(p=0.001)的比值显著更高。
与脓毒症中病理性宿主反应类似,危重病烧伤患者在前 2 天内 Angpt-2/Angpt-1 比值稳步升高,提示其可能参与烧伤毛细血管渗漏的发病机制。较高的 Angpt-2/Angpt-1 比值与死亡率、总烧伤面积和烧伤评分有关。